{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:47:11Z","timestamp":1790912831667,"version":"4.1.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.brainres.2022.148190","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T14:09:25Z","timestamp":1669903765000},"page":"148190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Linking nervous and immune systems in psychiatric illness: A meta-analysis of the kynurenine pathway"],"prefix":"10.1016","volume":"1800","author":[{"given":"Paulo M.G.","family":"Sales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra","family":"Schrage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Coico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Pato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2022.148190_b0005","unstructured":"Aarsland, T., Leskauskaite, I., Midttun, O., Ueland, P.M., Ulvik, A., Oltedal, L., Oedegaard, K., Haavik, J., Kessler, U., 2017. The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites, 30th ECNP Congress. European College of Neuropsychopharmacology (ECNP), Paris, France."},{"key":"10.1016\/j.brainres.2022.148190_b0010","doi-asserted-by":"crossref","DOI":"10.1177\/1756284818815334","article-title":"Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract","volume":"11","author":"Acovic","year":"2018","journal-title":"Therap. Adv. Gastroenterol."},{"key":"10.1016\/j.brainres.2022.148190_b0015","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.brainres.2022.148190_b0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpsychires.2018.02.011","article-title":"Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy","volume":"100","author":"Allen","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.brainres.2022.148190_b0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pnpbp.2017.04.022","article-title":"Linking the biological underpinnings of depression: Role of mitochondria interactions with melatonin, inflammation, sirtuins, tryptophan catabolites, DNA repair and oxidative and nitrosative stress, with consequences for classification and cognition","volume":"80","author":"Anderson","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2022.148190_b0030","doi-asserted-by":"crossref","DOI":"10.1177\/1178646917691938","article-title":"Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects","volume":"10","author":"Badawy","year":"2017","journal-title":"Int. J. Tryptophan Res.: IJTR"},{"key":"10.1016\/j.brainres.2022.148190_b0035","doi-asserted-by":"crossref","first-page":"e3968","DOI":"10.7717\/peerj.3968","article-title":"Revisiting the tryptophan-serotonin deficiency and the inflammatory hypotheses of major depression in a biopsychosocial approach","volume":"5","author":"Baranyi","year":"2017","journal-title":"PeerJ"},{"key":"10.1016\/j.brainres.2022.148190_b0040","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-gamma","volume":"15","author":"Boehm","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.brainres.2022.148190_b0045","doi-asserted-by":"crossref","first-page":"e865","DOI":"10.1038\/tp.2016.133","article-title":"An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation","volume":"6","author":"Brundin","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.brainres.2022.148190_b0050","doi-asserted-by":"crossref","unstructured":"Cervenka, I., Agudelo, L.Z., Ruas, J.L., 2017. Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health. Science (New York, N.Y.) 357.","DOI":"10.1126\/science.aaf9794"},{"key":"10.1016\/j.brainres.2022.148190_b0055","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1038\/npp.2016.66","article-title":"Tryptophan metabolism and white matter integrity in schizophrenia","volume":"41","author":"Chiappelli","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2022.148190_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychores.2017.05.016","article-title":"Sleep disturbance and kynurenine metabolism in depression","volume":"99","author":"Cho","year":"2017","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.brainres.2022.148190_b0065","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.psychres.2011.03.012","article-title":"The kynurenine pathway in major depression: haplotype analysis of three related functional candidate genes","volume":"188","author":"Claes","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.brainres.2022.148190_b0070","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1210\/me.2014-1108","article-title":"Minireview: Gut microbiota: the neglected endocrine organ","volume":"28","author":"Clarke","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.brainres.2022.148190_b0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.psyneuen.2015.02.011","article-title":"Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers","volume":"56","author":"Dahl","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.brainres.2022.148190_b0080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.brainres.2022.148190_b0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuropharm.2016.05.020","article-title":"The kynurenine pathway in schizophrenia and bipolar disorder","volume":"112","author":"Erhardt","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2022.148190_b0090","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00726-013-1602-1","article-title":"Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease","volume":"45","author":"Fatokun","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.brainres.2022.148190_b0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0026-0495(77)90057-9","article-title":"Effects on the diet on brain neurotransmitters","volume":"26","author":"Fernstrom","year":"1977","journal-title":"Metabolism"},{"key":"10.1016\/j.brainres.2022.148190_b0100","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2022.148190_b0105","doi-asserted-by":"crossref","first-page":"e101652","DOI":"10.1371\/journal.pone.0101652","article-title":"Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients","volume":"9","author":"Fukushima","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2022.148190_b0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00964611","article-title":"L-kynurenine: its synthesis and possible regulatory function in brain","volume":"5","author":"Gal","year":"1980","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2022.148190_b0115","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2022.148190_b0120","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41380-019-0634-7","article-title":"The genetics of bipolar disorder","volume":"25","author":"Gordovez","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2022.148190_b0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.dci.2013.08.003","article-title":"Antimicrobial responses of teleost phagocytes and innate immune evasion strategies of intracellular bacteria","volume":"43","author":"Grayfer","year":"2014","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.brainres.2022.148190_b0130","unstructured":"Higgins, J., Green, S.e., 2011. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration."},{"key":"10.1016\/j.brainres.2022.148190_b0135","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.brainres.2022.148190_b0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1503\/jpn.100175","article-title":"Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls","volume":"37","author":"Holtze","year":"2012","journal-title":"J. Psychiatry Neurosci.: JPN"},{"key":"10.1016\/j.brainres.2022.148190_b0145","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbi.2012.05.010","article-title":"Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation","volume":"26","author":"Hughes","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2022.148190_b0150","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-1781(94)90069-8","article-title":"A multidimensional approach to analysis of cerebrospinal fluid biogenic amines in schizophrenia: I. Comparisons with healthy control subjects and neuroleptic-treated\/unmedicated pairs analyses","volume":"52","author":"Issa","year":"1994","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.brainres.2022.148190_b0155","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00702-018-1838-8","article-title":"Kynurenine is correlated with IL-1beta in plasma of schizophrenia patients","volume":"125","author":"Joaquim","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.brainres.2022.148190_b0160","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s11011-017-9982-7","article-title":"Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway","volume":"32","author":"Kanchanatawan","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.brainres.2022.148190_b0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000213565","article-title":"Cytokine changes and tryptophan metabolites in medication-naive and medication-free schizophrenic patients","volume":"59","author":"Kim","year":"2009","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.brainres.2022.148190_b0175","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1471-4159.2002.00955.x","article-title":"Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain","volume":"82","author":"Kita","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2022.148190_b0180","first-page":"16","article-title":"High kynurenine (a tryptophan metabolite) predicts remission in patients with major depression to add-on treatment with celecoxib","volume":"8","author":"Krause","year":"2017","journal-title":"Front. Psych."},{"key":"10.1016\/j.brainres.2022.148190_b0185","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jad.2018.01.014","article-title":"Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naive patients with major depressive disorder: An exploratory pilot case-control study","volume":"231","author":"Kuwano","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.brainres.2022.148190_b0190","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/mp.2013.11","article-title":"The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression","volume":"19","author":"Lavebratt","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2022.148190_b0195","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","article-title":"The dual nature of type I and type II interferons","volume":"9","author":"Lee","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainres.2022.148190_b0200","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/schbul\/sbq086","article-title":"Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia","volume":"38","author":"Linderholm","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.brainres.2022.148190_b0205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41398-017-0056-8","article-title":"Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics","volume":"8","author":"Liu","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.brainres.2022.148190_b0210","first-page":"264","article-title":"Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity","volume":"32","author":"Maes","year":"2011","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.brainres.2022.148190_b0215","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.psychres.2011.09.029","article-title":"Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway","volume":"196","author":"Maes","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.brainres.2022.148190_b0220","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41398-018-0242-3","article-title":"Association of schizophrenia polygenic risk score with manic and depressive psychosis in bipolar disorder","volume":"8","author":"Markota","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.brainres.2022.148190_b0225","article-title":"The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies","author":"Marx","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2022.148190_b0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbi.2015.11.003","article-title":"Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder","volume":"53","author":"Meier","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2022.148190_b0235","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fpsyt.2019.00101","article-title":"Is the HPA Axis as Target for Depression Outdated, or Is There a New Hope?","volume":"10","author":"Menke","year":"2019","journal-title":"Front. Psych."},{"key":"10.1016\/j.brainres.2022.148190_b0240","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.immuni.2018.07.010","article-title":"The environmental sensor AHR protects from inflammatory damage by maintaining intestinal stem cell homeostasis and barrier integrity","volume":"49","author":"Metidji","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.brainres.2022.148190_b0245","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","article-title":"Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies","volume":"74","author":"Modabbernia","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2022.148190_b0250","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.brainres.2022.148190_b0255","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbi.2013.04.003","article-title":"Tryptophan metabolism and immunogenetics in major depression: a role for interferon-gamma gene","volume":"31","author":"Myint","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2022.148190_b0260","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jad.2006.12.008","article-title":"Tryptophan breakdown pathway in bipolar mania","volume":"102","author":"Myint","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.brainres.2022.148190_b0265","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.brainres.2022.148190_b0270","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.bbi.2011.05.005","article-title":"Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naive and medication-free schizophrenic patients","volume":"25","author":"Myint","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2022.148190_b0280","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41380-018-0220-4","article-title":"Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis","volume":"24","author":"Orlovska-Waast","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2022.148190_b0285","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jamapsychiatry.2014.16","article-title":"A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders","volume":"71","author":"Pedersen","year":"2014","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.brainres.2022.148190_b0290","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbw221","article-title":"Kynurenic acid in schizophrenia: a systematic review and meta-analysis","author":"Plitman","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.brainres.2022.148190_b0295","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00406-016-0731-4","article-title":"Kynurenine pathway and white matter microstructure in bipolar disorder","volume":"268","author":"Poletti","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.brainres.2022.148190_b0300","article-title":"An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder","author":"Pu","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2022.148190_b0305","doi-asserted-by":"crossref","first-page":"e69585","DOI":"10.1371\/journal.pone.0069585","article-title":"Induction of an inflammatory loop by interleukin-1\u03b2 and tumor necrosis factor-\u03b1 involves NF-kB and STAT-1 in differentiated human neuroprogenitor cells","volume":"8","author":"Pugazhenthi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2022.148190_b0310","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2022.148190_b0315","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/bdi.12166","article-title":"Tryptophan breakdown is increased in euthymic overweight individuals with bipolar disorder: a preliminary report","volume":"16","author":"Reininghaus","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.brainres.2022.148190_b0320","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cyto.2006.07.007","article-title":"NF-kappa B activation contributes to indoleamine dioxygenase transcriptional synergy induced by IFN-gamma and tumor necrosis factor-alpha","volume":"35","author":"Robinson","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.brainres.2022.148190_b0325","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41577-019-0125-8","article-title":"The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease","volume":"19","author":"Rothhammer","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.brainres.2022.148190_b0330","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","article-title":"The kynurenine pathway: a finger in every pie","volume":"25","author":"Savitz","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2022.148190_b0335","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.psyneuen.2015.07.609","article-title":"Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder","volume":"62","author":"Savitz","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.brainres.2022.148190_b0340","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.psyneuen.2014.11.015","article-title":"Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder","volume":"52","author":"Savitz","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.brainres.2022.148190_b0345","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature21080","article-title":"Feedback control of AHR signalling regulates intestinanl immunity","volume":"542","author":"Schiering","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2022.148190_b0350","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jclinepi.2018.01.012","article-title":"GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence","volume":"111","author":"Sch\u00fcnemann","year":"2019","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.brainres.2022.148190_b0355","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1503\/jpn.140126","article-title":"Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia\u2013significance for activation of the kynurenine pathway","volume":"40","author":"Schwieler","year":"2015","journal-title":"J. Psychiatry Neurosci.: JPN"},{"key":"10.1016\/j.brainres.2022.148190_b0360","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12974-016-0517-7","article-title":"Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients","volume":"13","author":"Schwieler","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.brainres.2022.148190_b0365","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2022.148190_b0370","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/mp.2015.186","article-title":"A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder","volume":"21","author":"Sellgren","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2022.148190_b0375","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jad.2017.06.052","article-title":"The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls","volume":"222","author":"Sorgdrager","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.brainres.2022.148190_b0380","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2174\/1389200220666190725115503","article-title":"The relationship between the serotonin metabolism, gut-microbiota and the gut-brain axis","volume":"20","author":"Stasi","year":"2019","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.brainres.2022.148190_b0385","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bbi.2011.05.002","article-title":"Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder","volume":"25","author":"Sublette","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2022.148190_b0390","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12640-017-9714-0","article-title":"Correlations of kynurenic acid, 3-hydroxykynurenine, sIL-2R, IFN-alpha, and IL-4 with clinical symptoms during acute relapse of schizophrenia","volume":"32","author":"Szymona","year":"2017","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.brainres.2022.148190_b0395","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1038\/s41598-017-05121-6","article-title":"Altered KYN\/TRP, Gln\/Glu, and Met\/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder","volume":"7","author":"Umehara","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2022.148190_b0400","article-title":"Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression","author":"Wang","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.brainres.2022.148190_b0405","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrn.2016.69","article-title":"Integrating neuroimmune systems in the neurobiology of depression","volume":"17","author":"Wohleb","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2022.148190_b0410","first-page":"1","article-title":"The effect of hormones and vitamin B6 on urinary excretion of metabolites of the kynurenine pathway","volume":"136","author":"Wolf","year":"1974","journal-title":"Scand. J. Clin. Lab. Invest. Suppl."},{"key":"10.1016\/j.brainres.2022.148190_b0415","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.schres.2014.10.026","article-title":"Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia","volume":"160","author":"Wonodi","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainres.2022.148190_b0420","doi-asserted-by":"crossref","first-page":"e1115","DOI":"10.1038\/tp.2017.88","article-title":"Serum kynurenic acid is reduced in affective psychosis","volume":"7","author":"Wurfel","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.brainres.2022.148190_b0425","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/mp.2009.33","article-title":"Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia","volume":"15","author":"Yao","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2022.148190_b0430","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbi.2016.04.007","article-title":"Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression","volume":"56","author":"Young","year":"2016","journal-title":"Brain Behav. Immun."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899322004140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899322004140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:22:57Z","timestamp":1757787777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899322004140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":84,"alternative-id":["S0006899322004140"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2022.148190","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linking nervous and immune systems in psychiatric illness: A meta-analysis of the kynurenine pathway","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2022.148190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"148190"}}